PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.54%
Negative revenue growth while RUN stands at 20.63%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-67.59%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-154.70%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-167.27%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-126.58%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-129.27%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-126.83%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.48%
Share reduction while RUN is at 50.13%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.13%
Diluted share reduction more than 1.5x RUN's 49.52%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-185.68%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-120.29%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
118.93%
10Y revenue/share CAGR above 1.5x RUN's 29.68%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-71.86%
Negative 5Y CAGR while RUN stands at 29.68%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-51.76%
Negative 3Y CAGR while RUN stands at 29.68%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-59829.12%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-185.54%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-283.83%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-3321.62%
Negative 10Y net income/share CAGR while RUN is at 55.94%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-159.04%
Negative 5Y net income/share CAGR while RUN is 55.94%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
22.92%
Below 50% of RUN's 55.94%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-3.86%
Negative equity/share CAGR over 10 years while RUN stands at 33.50%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-38.42%
Negative 5Y equity/share growth while RUN is at 33.50%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
27.56%
3Y equity/share CAGR at 75-90% of RUN's 33.50%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.29%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
9.37%
Inventory shrinking or stable vs. RUN's 37.28%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
10.53%
Asset growth above 1.5x RUN's 6.01%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-5.07%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
55.83%
Debt growth far above RUN's 17.20%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
29.59%
R&D growth drastically higher vs. RUN's 17.77%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
30.25%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.